FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, medicine and veterinary medicine. Use of substituted hydrazones of 5-arylfurfurols is proposed selected from CL-192, CL-193, CL-195 or CL-196, given in formula, as intracellular inhibitor of brucellosis infection. Compounds have inhibitory activity against intracellular brucellosis infection and do not show significant cytotoxic activity.
EFFECT: compounds can be used to create alternative antibiotics or combined medicinal and prophylactic means of protection against causative agent of human brucellosis.
1 cl, 4 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING PROTECTIVE IMMUNITY AGAINST CAUSATIVE AGENT OF BRUCELLOSIS | 2022 |
|
RU2806161C1 |
| POLYVALENT CORPUSCULAR ANTIGEN FOR PRODUCTION OF MEDICAL AND PREVENTIVE BIOLOGICAL PRODUCTS FOR BRUCELLOSIS | 2006 |
|
RU2330681C1 |
| METHOD FOR TREATMENT OF BRUCELLOSIS | 2002 |
|
RU2234311C1 |
| METHOD FOR TREATMENT OF BRUCELLOSIS | 2002 |
|
RU2239416C2 |
| METHOD FOR CONTROL OF ANTIBIOTIC EFFICIENCY IN TREATMENT OF BRUCELLOSIS | 2001 |
|
RU2206898C2 |
| STRAIN OF HYBRIDE CULTIVABLE MUS MUSCULUS L.CELLS PRODUCING MONOCLONAL ANTIBODIES TO BACTERIA OF BRUCELLA VARIETY | 0 |
|
SU1604848A1 |
| METHOD FOR OBTAINING PROTECTIVE EXTRACELLULAR BRUCELLA ANTIGEN CAPABLE TO PROVOKE CHRONIC FORMS OF BRUCELLOSIS | 2001 |
|
RU2199340C1 |
| METHOD FOR PRODUCTION OF BRUCELLAR MONOSPECIFIC SERUM ANTI-ABORTUS | 2008 |
|
RU2375074C1 |
| STRAIN OF F26 OF CONSTANT MONOCLONAL ANTIBODY LINE OF CELLS OF MUS MUSCULUS MOUSE - PRODUCER OF MONOCLONAL ANTIBODIES TO OLIGOPOLYSACCHARIDE (OPS) ANTIGEN B ABORTUS | 2014 |
|
RU2560260C1 |
| TRANSPORT LIQUID NUTRIENT MEDIUM FOR MAINTAINING THE VIABILITY OF THE BRUCELLOUS MICROBE | 2019 |
|
RU2725733C1 |
